⌘K

Login Start Free

Home/Filings/4/0001493152-22-006212

4//SEC Filing

Sax Adriann 4

Accession 0001493152-22-006212

CIK 0001310527other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 7:55 PM ET

Size

5.5 KB

Accession

0001493152-22-006212

Insider Transaction Report

Form 4

Period: 2022-03-03

QSAM Biosciences, Inc.QSAM

Director

Transactions

Award
Options to buy common stock
2022-03-03+750,000→ 750,000 total
Exercise: $0.25Exp: 2032-03-03→ Common Stock (750,000 underlying)

Footnotes (1)

[F1]The option vests annually in two equal installments beginning on 3/3/2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

QSAM Biosciences, Inc.

CIK 0001310527

Entity typeother

Related Parties

1

filerCIK 0001910140

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 7:55 PM ET
Size: 5.5 KB

View on SEC.gov